Jörg Felsberg

22.1k total citations · 4 hit papers
94 papers, 8.0k citations indexed

About

Jörg Felsberg is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Jörg Felsberg has authored 94 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 42 papers in Molecular Biology and 27 papers in Cancer Research. Recurrent topics in Jörg Felsberg's work include Glioma Diagnosis and Treatment (68 papers), Brain Metastases and Treatment (23 papers) and Epigenetics and DNA Methylation (16 papers). Jörg Felsberg is often cited by papers focused on Glioma Diagnosis and Treatment (68 papers), Brain Metastases and Treatment (23 papers) and Epigenetics and DNA Methylation (16 papers). Jörg Felsberg collaborates with scholars based in Germany, Switzerland and United States. Jörg Felsberg's co-authors include Guido Reifenberger, Michael Weller, Michael Sabel, Wolfgang Wick, Torsten Pietsch, Andreas von Deimling, Christian Hartmann, Marietta Wolter, Matthias Simon and Manfred Westphal and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jörg Felsberg

91 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

2009 868 citations Christian Hartmann, David Capper et al. Acta Neuropathologica profile →
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

2012 769 citations Wolfgang Wick, Jörg Felsberg et al. profile →
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

2010 627 citations Christian Hartmann, Bettina Hentschel et al. Acta Neuropathologica profile →
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

2009 571 citations Wolfgang Wick, Christian Hartmann et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Felsberg Germany	40	6.1k	3.2k	2.6k	2.1k	1.3k	94	8.0k
Ahmed Idbaïh France	48	5.4k 0.9×	3.4k 1.1×	2.6k 1.0×	1.8k 0.9×	1.4k 1.1×	259	9.7k
Andrew B. Lassman United States	44	5.8k 0.9×	1.9k 0.6×	1.5k 0.6×	3.0k 1.4×	2.0k 1.6×	191	8.8k
Karima Mokhtari France	57	7.2k 1.2×	3.3k 1.0×	2.6k 1.0×	2.6k 1.2×	1.5k 1.1×	234	10.7k
Daniel P. Cahill United States	44	4.2k 0.7×	4.3k 1.3×	2.5k 1.0×	1.5k 0.7×	1.3k 1.0×	176	9.7k
Ryo Nishikawa Japan	40	4.3k 0.7×	3.3k 1.0×	1.9k 0.7×	1.7k 0.8×	959 0.7×	201	8.4k
David R. Macdonald Canada	34	8.1k 1.3×	1.8k 0.6×	1.7k 0.7×	3.2k 1.5×	2.8k 2.2×	77	9.7k
Enrico Franceschi Italy	38	4.1k 0.7×	1.4k 0.4×	1.1k 0.4×	2.0k 1.0×	1.1k 0.9×	193	5.8k
Annie‐Claire Diserens Switzerland	22	4.9k 0.8×	3.8k 1.2×	2.4k 0.9×	1.6k 0.8×	812 0.6×	27	8.0k
Erik P. Sulman United States	52	3.7k 0.6×	5.2k 1.6×	3.1k 1.2×	2.1k 1.0×	968 0.8×	223	10.5k
Marie‐France Hamou Switzerland	31	5.3k 0.9×	4.1k 1.3×	2.7k 1.0×	1.8k 0.9×	894 0.7×	46	9.0k

Countries citing papers authored by Jörg Felsberg

Since Specialization

Citations

This map shows the geographic impact of Jörg Felsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Felsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Felsberg more than expected).

Fields of papers citing papers by Jörg Felsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Felsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Felsberg. The network helps show where Jörg Felsberg may publish in the future.

Co-authorship network of co-authors of Jörg Felsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Felsberg. A scholar is included among the top collaborators of Jörg Felsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Felsberg. Jörg Felsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weller, Michael, Jörg Felsberg, Bettina Hentschel, et al.. (2024). Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma. Acta Neuropathologica. 147(1). 27 indexed citations

Wirsching, Hans‐Georg, Jörg Felsberg, Michael Prummer, et al.. (2023). Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival. Acta Neuropathologica. 146(4). 647–649. 3 indexed citations

Gramatzki, Dorothee, Jörg Felsberg, Bettina Hentschel, et al.. (2021). Chemotherapy for adult patients with spinal cord gliomas. Neuro-Oncology Practice. 8(4). 475–484. 4 indexed citations

Gramatzki, Dorothee, Jörg Felsberg, Patrick Roth, et al.. (2020). The molecular evolution of glioblastoma treated by gross total resection alone. Neuro-Oncology. 23(2). 334–336. 2 indexed citations

Mughal, Sadaf S., Sarah Teuber‐Hanselmann, Daniela Pierscianek, et al.. (2020). Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain. Frontiers in Immunology. 11. 120–120. 32 indexed citations

Witt, Hendrik, Dorothee Gramatzki, Bettina Hentschel, et al.. (2018). DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment. Neuro-Oncology. 20(12). 1616–1624. 59 indexed citations

Zacher, Angela, Kerstin Kaulich, Stefanie Stepanow, et al.. (2016). Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel. Brain Pathology. 27(2). 146–159. 121 indexed citations

Jelínek, F, et al.. (2013). Familial incidence of mammary gland tumours in the Djungarian hamster (Phodopus sungaros): a case report. Veterinární Medicína. 58(8). 442–448. 2 indexed citations

Delic, Sabit, Anja Stelzl, Marietta Wolter, et al.. (2013). MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro-Oncology. 16(2). 179–190. 79 indexed citations

10.

Felsberg, Jörg, Anke Waha, Anke Waha, et al.. (2012). RANK (TNFRSF11A) Is Epigenetically Inactivated and Induces Apoptosis in Gliomas. Neoplasia. 14(6). 526–IN12. 22 indexed citations

11.

Campos, Benito, Justo Lorenzo Bermejo, Ramadan Ali, et al.. (2011). Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas. American Journal Of Pathology. 178(5). 1953–1964. 57 indexed citations

12.

Traenka, Christopher, Marc Remke, Andrey Korshunov, et al.. (2010). Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma. Cancer Research. 70(20). 8003–8014. 55 indexed citations

13.

Waha, Anke, Jörg Felsberg, Wolfgang Hartmann, et al.. (2010). Epigenetic Downregulation of Mitogen-Activated Protein Kinase Phosphatase MKP-2 Relieves Its Growth Suppressive Activity in Glioma Cells. Cancer Research. 70(4). 1689–1699. 67 indexed citations

14.

Temme, Achim, Kathrin Geiger, Ralf Wiedemuth, et al.. (2010). Giant Cell Glioblastoma Is Associated With Altered Aurora B Expression and Concomitant p53 Mutation. Journal of Neuropathology & Experimental Neurology. 69(6). 632–642. 24 indexed citations

15.

Ernst, Aurélie, Stefanie Hofmann, Rezvan Ahmadi, et al.. (2009). Genomic and Expression Profiling of Glioblastoma Stem Cell–Like Spheroid Cultures Identifies Novel Tumor-Relevant Genes Associated with Survival. Clinical Cancer Research. 15(21). 6541–6550. 150 indexed citations

16.

Pfister, Stefan M., Marc Remke, Axel Benner, et al.. (2009). Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci. Journal of Clinical Oncology. 27(10). 1627–1636. 198 indexed citations

17.

Wick, Wolfgang, Christian Hartmann, Corinna Engel, et al.. (2009). NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide. Journal of Clinical Oncology. 27(35). 5874–5880. 571 indexed citations breakdown →

18.

Felsberg, Jörg, Marion Rapp, Simon Loeser, et al.. (2009). Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients. Clinical Cancer Research. 15(21). 6683–6693. 153 indexed citations

19.

Weller, Michael, Jörg Felsberg, Christian Hartmann, et al.. (2009). Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network. Journal of Clinical Oncology. 27(34). 5743–5750. 476 indexed citations

20.

Versmold, Beatrix, Jörg Felsberg, Thomas Mikeska, et al.. (2007). Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. International Journal of Cancer. 121(3). 547–554. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact